JP2022510700A5 - - Google Patents

Info

Publication number
JP2022510700A5
JP2022510700A5 JP2021532119A JP2021532119A JP2022510700A5 JP 2022510700 A5 JP2022510700 A5 JP 2022510700A5 JP 2021532119 A JP2021532119 A JP 2021532119A JP 2021532119 A JP2021532119 A JP 2021532119A JP 2022510700 A5 JP2022510700 A5 JP 2022510700A5
Authority
JP
Japan
Prior art keywords
methyl
hydroxy
phenyl
oxo
dihydropyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021532119A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022510700A (ja
Filing date
Publication date
Priority claimed from GBGB1819936.4A external-priority patent/GB201819936D0/en
Priority claimed from GBGB1904341.3A external-priority patent/GB201904341D0/en
Application filed filed Critical
Priority claimed from PCT/GB2019/053456 external-priority patent/WO2020115500A1/en
Publication of JP2022510700A publication Critical patent/JP2022510700A/ja
Publication of JP2022510700A5 publication Critical patent/JP2022510700A5/ja
Pending legal-status Critical Current

Links

JP2021532119A 2018-12-06 2019-12-06 治療において使用するusp19阻害剤 Pending JP2022510700A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1819936.4 2018-12-06
GBGB1819936.4A GB201819936D0 (en) 2018-12-06 2018-12-06 Therapeutic methods
GBGB1904341.3A GB201904341D0 (en) 2019-03-28 2019-03-28 Therapeutic methods
GB1904341.3 2019-03-28
PCT/GB2019/053456 WO2020115500A1 (en) 2018-12-06 2019-12-06 Usp19 inhibitors for use in therapy

Publications (2)

Publication Number Publication Date
JP2022510700A JP2022510700A (ja) 2022-01-27
JP2022510700A5 true JP2022510700A5 (cg-RX-API-DMAC7.html) 2023-01-11

Family

ID=68887434

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021532119A Pending JP2022510700A (ja) 2018-12-06 2019-12-06 治療において使用するusp19阻害剤

Country Status (12)

Country Link
US (1) US20220016115A1 (cg-RX-API-DMAC7.html)
EP (1) EP3890737B1 (cg-RX-API-DMAC7.html)
JP (1) JP2022510700A (cg-RX-API-DMAC7.html)
KR (1) KR20210100127A (cg-RX-API-DMAC7.html)
CN (1) CN113395965A (cg-RX-API-DMAC7.html)
AU (1) AU2019393161A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021010645A2 (cg-RX-API-DMAC7.html)
CA (1) CA3121422A1 (cg-RX-API-DMAC7.html)
IL (1) IL283687A (cg-RX-API-DMAC7.html)
MX (1) MX2021006542A (cg-RX-API-DMAC7.html)
SG (1) SG11202105911PA (cg-RX-API-DMAC7.html)
WO (1) WO2020115500A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3134564A1 (en) * 2019-05-06 2020-11-12 Lawrence Marcin Inhibiting usp19
GB202104097D0 (en) * 2021-03-24 2021-05-05 Almac Discovery Ltd Pharmaceutical compounds
GB202311227D0 (en) 2023-07-21 2023-09-06 Almac Discovery Ltd Pharmaceutical compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO111096A0 (en) * 1996-07-18 1996-08-08 Fujisawa Pharmaceutical Co., Ltd. New compound
WO2009072643A1 (en) 2007-12-03 2009-06-11 Takeda Pharmaceutical Company Limited Nitrogen-containing heterocyclic compound and use thereof
CN104174021A (zh) * 2013-05-22 2014-12-03 复旦大学附属华山医院 蛋白酶体抑制剂在制备治疗慢性低度炎症性疾病药物中的用途
TWI698436B (zh) * 2014-12-30 2020-07-11 美商佛瑪治療公司 作為泛素特異性蛋白酶7抑制劑之吡咯并及吡唑并嘧啶
GB201612938D0 (en) * 2016-07-26 2016-09-07 Almac Discovery Ltd Pharmaceutical compounds
AU2018342089B2 (en) * 2017-09-26 2024-07-11 Dana-Farber Cancer Institute, Inc. Novel USP7 inhibitors for treating multiple myeloma
GB201801562D0 (en) * 2018-01-31 2018-03-14 Almac Diagnostics Ltd Pharmaceutical compounds

Similar Documents

Publication Publication Date Title
JP2019523266A5 (cg-RX-API-DMAC7.html)
JP2007519754A5 (cg-RX-API-DMAC7.html)
RU2454405C2 (ru) Производные 3-пиридинкарбоксамида и 2-пиразинкарбоксамида в качестве агентов, повышающих уровень лвп-холестерина
AU2016263156B2 (en) Heterocyclic amides as kinase inhibitors
US9242977B2 (en) Trk-inhibiting compound
AU2012308681B2 (en) Aminopyrimidine derivatives for use as modulators of kinase activity
HRP20201430T1 (hr) Spojevi 6-heterociklil-4-morfolin-4-ilpiridin-2-ona korisni za liječenje karcinoma i dijabetesa
HRP20250519T1 (hr) Supstituirani aminotiazoli kao inhibitori dgkzeta za imunološku aktivaciju
JP2019537571A5 (cg-RX-API-DMAC7.html)
JP2016519156A5 (cg-RX-API-DMAC7.html)
CA2583907A1 (en) Heteroaryl-substituted alkyne compounds and method of use
RU2011107437A (ru) Ингибиторы кинуренин-3-моноксигеназы
RU2010110640A (ru) Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ
RU2015154987A (ru) Гетероциклические производные
JP2015531773A (ja) スルファモイル−アリールアミド及びb型肝炎の治療のための薬剤としてのその使用
JP2010508338A5 (cg-RX-API-DMAC7.html)
RS56424B1 (sr) Piridin-2-amidi korisni kao cb2-agonisti
JP2019505595A5 (cg-RX-API-DMAC7.html)
US20170096405A1 (en) Novel compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same
JP2017500364A5 (cg-RX-API-DMAC7.html)
JP6208212B2 (ja) 呼吸器疾患用薬
RU2018104868A (ru) 2-амино-3-фтор-3-(фторметил)-6-метил-6-фенил-3,4,5,6-тетрагидропиридины в качестве ингибиторов bace1
KR20150120516A (ko) 2-아실아미노티아졸 유도체 또는 그의 염
JP2018515489A5 (cg-RX-API-DMAC7.html)
AU2016317806A1 (en) Heteroaryl compounds and their use as therapeutic drugs